Open-label adjunctive topiramate in the treatment of bipolar disorders
Authors:
- Trisha SuppesTSTrisha Suppes
- Paul E KeckPKPaul E Keck
- Mark A FryeMFMark A Frye
- Kirk D DenicoffKDKirk D Denicoff
- Lori L AltshulerLALori L Altshuler
- E.SHerwood BrownEBE.SHerwood Brown
- Willem A NolenWNWillem A Nolen
- Ralph W KupkaRKRalph W Kupka
- Jennifer RochussenJRJennifer Rochussen
- Gabriele S LeverichGLGabriele S Leverich
- Robert M PostRPRobert M Post
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 47 (12) , 1025-1033
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Topiramate as add‐on treatment for patients with bipolar maniaBipolar Disorders, 1999
- Mood Stabilization and Weight Loss With TopiramateAmerican Journal of Psychiatry, 1999
- A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I DepressionThe Journal of Clinical Psychiatry, 1999
- Use of topiramate, a new anti-epileptic as a mood stabilizerJournal of Affective Disorders, 1998
- Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortexProceedings of the National Academy of Sciences, 1998
- Life Charting of Affective DisordersCNS Spectrums, 1998
- TopiramateDrugs, 1997
- The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphatesProceedings of the National Academy of Sciences, 1997
- Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial SeizuresEpilepsia, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosagesNeurology, 1996